10,000+ stock pitches from top investors available on joinyellowbrick.com
BAKER BROS. ADVISORS LP 13F Holdings
Holdings from the most recent 13F from BAKER BROS. ADVISORS LP
Filed: 2023-05-15 (Q1 2023) | Holdings: 105 | Value: $18.4B | Filing Link
PREMIUM
Author Returns
Returns are calculated from when the filing is published and are weighted by the size of the holding.
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Filing Returns
Returns are calculated from when the filing is published and are weighted by the size of the holding.
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Holding Returns | |||||||
|---|---|---|---|---|---|---|---|
| Stock | Put/Call | Change | Holding Pct | Value | Current Return | 3M Return | 1Y Return |
| SGEN - Seagen Inc. | 51.68% | $9.5B | +1.88% | ||||
| INCY - Incyte Corporation | 14.22% | $2.6B | -1.00% | -1.51% | -13.48% | ||
| BGNE - BeiGene, Ltd. | 13.68% | $2.5B | +0.60% | -21.21% | -29.94% | ||
| ACAD - ACADIA Pharmaceuticals Inc. | 4.29% | $789.3M | -1.01% | +34.24% | -31.85% | ||
| MDGL - Madrigal Pharmaceuticals, Inc. | 2.04% | $374.3M | -1.98% | -37.47% | -22.67% | ||
| BMRN - BioMarin Pharmaceutical Inc. | Reduce 50% $(370.5M) | 2.02% | $370.5M | -37.97% | -3.86% | -17.78% | |
| IMCR - Immunocore Holdings plc | 0.68% | $124.6M | -39.02% | -0.55% | -9.61% | ||
| RYTM - Rhythm Pharmaceuticals, Inc. | Add 2% ($2.6M) | 0.63% | $115.9M | +271.02% | +54.02% | +136.96% | |
| KOD - Kodiak Sciences Inc. | 0.58% | $107.3M | -35.48% | -50.85% | -29.03% | ||
| BCRX - BioCryst Pharmaceuticals, Inc. | 0.58% | $106.0M | +25.73% | -19.06% | -24.33% | ||
| ARGX - argenx SE | 0.57% | $104.4M | +45.29% | +27.22% | -4.55% | ||
| AKRO - Akero Therapeutics, Inc. | 0.49% | $90.6M | +7.98% | +0.91% | -54.92% | ||
| KYMR - Kymera Therapeutics, Inc. | 0.46% | $85.3M | +1.72% | -33.91% | +22.17% | ||
| REPL - Replimune Group, Inc. | 0.44% | $80.9M | -50.90% | +2.79% | -63.26% | ||
| ABCL - AbCellera Biologics Inc. | 0.43% | $78.8M | -65.82% | -6.94% | -36.04% | ||
| SWTX - SpringWorks Therapeutics, Inc. | Add 80% ($31.5M) | 0.39% | $70.9M | +55.80% | -5.04% | +49.33% | |
| TRDA - Entrada Therapeutics, Inc. | 0.38% | $70.6M | -40.63% | +22.81% | +16.80% | ||
| BMEA - Biomea Fusion, Inc. | 0.36% | $65.4M | -95.74% | -49.94% | -62.18% | ||
| RVMD - Revolution Medicines, Inc. | New Purchase | 0.32% | $58.3M | +52.06% | +15.40% | +50.48% | |
| PRLD - Prelude Therapeutics Inc. | 0.31% | $57.7M | -86.82% | -46.88% | -36.31% | ||
| MRTX - Mirati Therapeutics, Inc. | 0.29% | $52.4M | -18.47% | ||||
| FGEN - FibroGen, Inc. | Add 92% ($23.6M) | 0.27% | $49.2M | -98.34% | -92.49% | -92.84% | |
| CERS - Cerus Corporation | 0.26% | $47.7M | -32.80% | -4.76% | +3.70% | ||
| IGMS - IGM Biosciences, Inc. | 0.24% | $43.4M | -90.55% | -45.24% | -30.88% | ||
| AVTE - Aerovate Therapeutics, Inc. | Reduce 1% $(270.1K) | 0.22% | $39.6M | -26.02% | +8.20% | ||
| IMTX - Immatics N.V. | 0.19% | $35.8M | -45.11% | +15.89% | +10.08% | ||
| ROIV - Roivant Sciences Ltd. | New Purchase | 0.19% | $35.3M | +19.07% | +17.12% | +23.62% | |
| NRIX - Nurix Therapeutics, Inc. | 0.19% | $34.5M | +0.95% | -18.33% | +46.25% | ||
| KDNY - Chinook Therapeutics, Inc. | Reduce 43% $(25.0M) | 0.18% | $33.7M | ||||
| KNSA - Kiniksa Pharmaceuticals, Ltd. | 0.16% | $30.1M | +94.73% | +16.94% | +43.13% | ||
| DICE - DICE Therapeutics, Inc. | Add 20% ($5.0M) | 0.16% | $29.7M | ||||
| XENE - Xenon Pharmaceuticals Inc. | 0.15% | $26.9M | -30.77% | -12.48% | -3.19% | ||
| TSVT - 2seventy bio, Inc. | Add 21% ($4.4M) | 0.14% | $25.5M | -50.22% | -56.52% | ||
| DNLI - Denali Therapeutics Inc. | 0.14% | $25.1M | -57.81% | -24.98% | -35.50% | ||
| DBVT - DBV Technologies S.A. | 0.13% | $24.7M | -60.98% | -28.50% | -72.38% | ||
| KRYS - Krystal Biotech, Inc. | 0.13% | $24.2M | +41.86% | +37.40% | +84.46% | ||
| VERV - Verve Therapeutics, Inc. | 0.11% | $20.4M | -74.28% | -13.18% | -63.12% | ||
| RARE - Ultragenyx Pharmaceutical Inc. | 0.10% | $18.9M | -28.91% | -22.46% | -10.99% | ||
| BCYC - Bicycle Therapeutics plc | 0.10% | $17.9M | -65.02% | -6.09% | -5.62% | ||
| STOK - Stoke Therapeutics, Inc. | New Purchase | 0.10% | $17.6M | -17.40% | -52.81% | +21.47% | |
| ANAB - AnaptysBio, Inc. | 0.09% | $16.9M | +16.57% | +1.31% | +33.56% | ||
| RNA - Avidity Biosciences, Inc. | New Purchase | 0.08% | $15.4M | +180.36% | -24.07% | +159.91% | |
| BPMC - Blueprint Medicines Corporation | New Purchase | 0.08% | $15.0M | +88.03% | -7.98% | +97.85% | |
| SPRY - ARS Pharmaceuticals, Inc. | 0.07% | $13.1M | +87.16% | -11.02% | +18.03% | ||
| PACB - Pacific Biosciences of California, Inc. | New Purchase | 0.07% | $13.1M | -92.23% | -13.70% | -82.35% | |
| PRME - Prime Medicine, Inc. | 0.07% | $12.7M | -90.80% | -9.28% | -45.09% | ||
| HRTX - Heron Therapeutics, Inc. | 0.07% | $12.3M | +40.30% | +21.64% | +140.30% | ||
| NVTA - Invitae Corporation | Add 6% ($646.7K) | 0.07% | $12.0M | -19.05% | -99.84% | ||
| IDYA - IDEAYA Biosciences, Inc. | Reduce 50% $(11.5M) | 0.06% | $11.4M | -7.75% | +17.21% | +92.63% | |
| CABA - Cabaletta Bio, Inc. | New Purchase | 0.06% | $11.1M | -83.88% | +12.93% | +8.79% | |
| ADAP - Adaptimmune Therapeutics plc | Reduce 100% | 0.00% | $0.00 | ||||
| ASND - Ascendis Pharma A/S | Reduce 100% | 0.00% | $0.00 | ||||
| BLUE - bluebird bio, Inc. | Reduce 100% | 0.00% | $0.00 | ||||
| N/A - Insmed Incorporated | Reduce 100% | 0.00% | $0.00 | ||||
| OPT - Opthea Limited | Reduce 100% | 0.00% | $0.00 | ||||
| TVTX - Travere Therapeutics, Inc. | Reduce 100% | 0.00% | $0.00 | ||||
| HZNP - Horizon Therapeutics Public Ltd Co | Reduce 100% | 0.00% | $0.00 | ||||